Loading…
Loading grant details…
| Funder | European Commission |
|---|---|
| Recipient Organization | Solmegia Monoprosopi I.K.E. |
| Country | Greece |
| Start Date | Sep 01, 2024 |
| End Date | Aug 31, 2026 |
| Duration | 729 days |
| Number of Grantees | 1 |
| Roles | Coordinator |
| Data Source | European Commission |
| Grant ID | 101188544 |
REVOLUTIONIZING FOOD PRODUCTION WITH CO2 INPUTS AND CARBON-NEGATIVE MICROALGAEE PROTEINSSolmeyea is a biotech company producing functional food ingredients as an alternative to both animal- & plant-based proteins.
Our groundbreaking, IP-protected Hybrid Vertical Microalgae Fermentation (HVF) technology, enables microalgae fermentation using CO2 in lieu of carbon substrates and Greece's abundant Renewable Energy Sources.
This combination results in the production of carbon-negative, microalgae-derived proteins in various colors requiring 0.1% of the crops-land on 200x higher yields of the same proteins.ENHANCING FOOD SECURITY, GEOPOLITICS & ECONOMIC IMPACTOur HVF not only unlocks the full potential of microalgae but also addresses EUs critical challenges, reducing reliance on heavily commoditized and price-volatile crops and glucose.
We support food security, facilitate the production of fermented CO2-derived food proteins and replace imported, highly processed and environmentally harmful crop-derived ones.
We ensure the efficient production of food ingredients, contributing to national and EU GDP and empower the EU to regain independence and geopolitical competitiveness.
SOLUTION: MEY PROTEIN FOR HUMAN CONSUMPTION AT SCALEMEY is the first-ever non-GMO protein produced from CO2 with the highest standards for human consumption.
Through the pioneering combination of gas and microalgae fermentation, we transform SCOPE:1 CO2 into authorized, white, functional food protein.
Compared to any FDA/EFSA-approved protein, our microalgae-derived MEY demonstrate 30x higher land-efficiency and 400x more sustainable in terms of water and carbon footprint.EICA SUPPORT: ADVANCING TECHNOLOGY TO TRL:9 AND BEYONDIt will propel Solmeyea's CO2-Bioconversion and microalgae fermentation system to (TRL) 9, projecting an annual revenue of 190 million by 2029.
Our integrated AI models ensure precision, efficiency and cost-effectiveness at both our demo and future flagship devel
Solmegia Monoprosopi I.K.E.
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant